{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-107345","form_type":"8-K","ticker":"IRIX","cik":"0001006045","company_name":"IRIDEX CORP","filed_at":"2025-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.116583+00:00","generated_at":"2026-05-17T14:11:51.846323+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Iridex Q2 revenue $13.6M (+7% YoY), net loss narrows to $1.0M; third straight positive adjusted EBITDA","bullets":["Revenue $13.6M, up 7% YoY and 14% sequential; retina product revenue $8.0M (+10% YoY).","Cyclo G6 revenue $3.3M (flat YoY); sold 13,100 probes vs 15,100, and 35 systems vs 28.","Gross margin 34.5% vs 40.7% a year ago due to higher costs and product mix.","Operating expenses down 28% YoY to $5.6M; net loss $1.0M ($0.06/sh) vs $2.7M ($0.16/sh).","Non-GAAP adjusted EBITDA positive $21k, vs loss of $1.7M; cash $6.8M, down $0.4M in quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-107345","json":"https://secwatch.observer/filing/0000950170-25-107345.json","markdown":"https://secwatch.observer/filing/0000950170-25-107345.md","text":"https://secwatch.observer/filing/0000950170-25-107345.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1006045/000095017025107345/0000950170-25-107345-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1006045/000095017025107345/irix-20250812.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T14:11:51.846323+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}